NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.
Letter to PBM on Medication Access
04/28/2021
Letter to Express Scripts, expressing concern regarding Express Scripts’ 2021 National Preferred Formulary Exclusion List placement of Parkinson’s and tardive dyskinesia medications.
Letter to Congressional Leadership on Health Coverage & COVID-19
04/23/2021
Letter to Congressional leadership, urging Congress to enact additional legislation that will help support the health and wellbeing of the American public while also slowing the spread of the COVID-19 virus, particularly among vulnerable populations.
Letter to CDC Director on COVID-19
04/15/2021
Letter to CDC Director Walensky, urging the CDC to add schizophrenia-spectrum disorders and related disorders to the list of underlying conditions eligible for the COVID-19 vaccine.